FCA
MRTX

FinTrust Capital Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

FinTrust Capital Advisors’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-7
Closed -$392 – 1294
2023
Q4 		$392 Hold
7
– – ﹤0.01% 1170
2023
Q3 		$291 Buy
+7
New +$291 ﹤0.01% 1172